Present at the revolution: transformation of technical identity for a large incumbent pharmaceutical firm after the biotechnological breakthrough
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Buch |
| Sprache: | Undetermined |
| Veröffentlicht: |
Cambridge, Mass.
1995
|
| Schriftenreihe: | Working paper series / National Bureau of Economic Research
5243 |
| Beschreibung: | 42 S. graph. Darst. |
Internformat
MARC
| LEADER | 00000nam a22000001cb4500 | ||
|---|---|---|---|
| 001 | BV026947251 | ||
| 003 | DE-604 | ||
| 005 | 20110228 | ||
| 007 | t | ||
| 008 | 110326s1995 d||| |||| 00||| und d | ||
| 035 | |a (OCoLC)174002850 | ||
| 035 | |a (DE-599)BVBBV026947251 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | |a und | ||
| 049 | |a DE-188 | ||
| 100 | 1 | |a Zucker, Lynne G. |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Present at the revolution |b transformation of technical identity for a large incumbent pharmaceutical firm after the biotechnological breakthrough |c Lynne G. Zucker ; Michael R. Darby |
| 264 | 1 | |a Cambridge, Mass. |c 1995 | |
| 300 | |a 42 S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Working paper series / National Bureau of Economic Research |v 5243 | |
| 700 | 1 | |a Darby, Michael R. |e Sonstige |4 oth | |
| 810 | 2 | |a National Bureau of Economic Research |t Working paper series |v 5243 |w (DE-604)BV002801238 |9 5243 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-021608379 | ||
Datensatz im Suchindex
| _version_ | 1804144406717005824 |
|---|---|
| any_adam_object | |
| author | Zucker, Lynne G. |
| author_facet | Zucker, Lynne G. |
| author_role | aut |
| author_sort | Zucker, Lynne G. |
| author_variant | l g z lg lgz |
| building | Verbundindex |
| bvnumber | BV026947251 |
| ctrlnum | (OCoLC)174002850 (DE-599)BVBBV026947251 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01021nam a22002771cb4500</leader><controlfield tag="001">BV026947251</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20110228 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">110326s1995 d||| |||| 00||| und d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)174002850</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV026947251</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">und</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-188</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Zucker, Lynne G.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Present at the revolution</subfield><subfield code="b">transformation of technical identity for a large incumbent pharmaceutical firm after the biotechnological breakthrough</subfield><subfield code="c">Lynne G. Zucker ; Michael R. Darby</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cambridge, Mass.</subfield><subfield code="c">1995</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">42 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Working paper series / National Bureau of Economic Research</subfield><subfield code="v">5243</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Darby, Michael R.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="810" ind1="2" ind2=" "><subfield code="a">National Bureau of Economic Research</subfield><subfield code="t">Working paper series</subfield><subfield code="v">5243</subfield><subfield code="w">(DE-604)BV002801238</subfield><subfield code="9">5243</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-021608379</subfield></datafield></record></collection> |
| id | DE-604.BV026947251 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T23:03:03Z |
| institution | BVB |
| language | Undetermined |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-021608379 |
| oclc_num | 174002850 |
| open_access_boolean | |
| owner | DE-188 |
| owner_facet | DE-188 |
| physical | 42 S. graph. Darst. |
| publishDate | 1995 |
| publishDateSearch | 1995 |
| publishDateSort | 1995 |
| record_format | marc |
| series2 | Working paper series / National Bureau of Economic Research |
| spelling | Zucker, Lynne G. Verfasser aut Present at the revolution transformation of technical identity for a large incumbent pharmaceutical firm after the biotechnological breakthrough Lynne G. Zucker ; Michael R. Darby Cambridge, Mass. 1995 42 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier Working paper series / National Bureau of Economic Research 5243 Darby, Michael R. Sonstige oth National Bureau of Economic Research Working paper series 5243 (DE-604)BV002801238 5243 |
| spellingShingle | Zucker, Lynne G. Present at the revolution transformation of technical identity for a large incumbent pharmaceutical firm after the biotechnological breakthrough |
| title | Present at the revolution transformation of technical identity for a large incumbent pharmaceutical firm after the biotechnological breakthrough |
| title_auth | Present at the revolution transformation of technical identity for a large incumbent pharmaceutical firm after the biotechnological breakthrough |
| title_exact_search | Present at the revolution transformation of technical identity for a large incumbent pharmaceutical firm after the biotechnological breakthrough |
| title_full | Present at the revolution transformation of technical identity for a large incumbent pharmaceutical firm after the biotechnological breakthrough Lynne G. Zucker ; Michael R. Darby |
| title_fullStr | Present at the revolution transformation of technical identity for a large incumbent pharmaceutical firm after the biotechnological breakthrough Lynne G. Zucker ; Michael R. Darby |
| title_full_unstemmed | Present at the revolution transformation of technical identity for a large incumbent pharmaceutical firm after the biotechnological breakthrough Lynne G. Zucker ; Michael R. Darby |
| title_short | Present at the revolution |
| title_sort | present at the revolution transformation of technical identity for a large incumbent pharmaceutical firm after the biotechnological breakthrough |
| title_sub | transformation of technical identity for a large incumbent pharmaceutical firm after the biotechnological breakthrough |
| volume_link | (DE-604)BV002801238 |
| work_keys_str_mv | AT zuckerlynneg presentattherevolutiontransformationoftechnicalidentityforalargeincumbentpharmaceuticalfirmafterthebiotechnologicalbreakthrough AT darbymichaelr presentattherevolutiontransformationoftechnicalidentityforalargeincumbentpharmaceuticalfirmafterthebiotechnologicalbreakthrough |